Intratumoural viral delivery improves glioblastoma survival
“Injecting a virus into a patient’s brain tumour” combined with immunotherapy improved glioblastoma survival outcomes in a clinical trial.
List view / Grid view
“Injecting a virus into a patient’s brain tumour” combined with immunotherapy improved glioblastoma survival outcomes in a clinical trial.
NaviFUS® was approved by the Taiwan FDA for use in a new clinical trial for the treatment of terminal primary brain tumours.
Scientists have proposed combining ultrasound with other techniques to improve drug transport into brain tumours.
Researchers have used a fluorescent marker to aid surgeons in locating high-grade brain tumour cells, enabling accurate and safe removal...
The study focused on children and young adults receiving proton radiotherapy for brain tumours...
A research team have reported the first NIR-II fluorescent molecule with aggregation-induced-emission (AIE) characteristics for dual fluorescence and photoacoustic imaging...